A recent analysis suggests that people who start GLP-1 medications such as Ozempic, Wegovy, or Mounjaro tend to do less physical activity after beginning treatment — even though…
Shaquille O’Neal says a GLP-1 medication called Zepbound has helped reduce his obstructive sleep apnea (OSA) symptoms and support weight loss.
AstraZeneca’s experimental oral GLP-1 drug elecoglipron produced substantial reductions in body weight and blood sugar in a phase 2b trial, offering another noninjectable option in the…
New research suggests that regularly adding avocado to your diet can improve markers linked to diabetes, high blood pressure, and cardiometabolic risk.
A growing body of reports and a new observational study suggest that GLP-1 medications such as Ozempic, Wegovy and Mounjaro can do more than lower appetite: they appear to reduce…
A large Danish registry study suggests that adults who start semaglutide for weight management may use fewer triptans — but the effect appears to be driven mainly by women.
A new meta-analysis of phase 3 trials finds that GLP-1 receptor agonists—drugs such as Ozempic, Wegovy, and newer multi-hormone receptor modulators (MHRMs)—are associated with…
An oral tablet version of semaglutide—marketed as Ozempic in injectable form—is now available in the United States.
Boehringer Ingelheim reported positive Phase 3 findings from the SYNCHRONIZE-1 trial of survodutide (BI 456906), a next-generation injectable that activates both GLP-1 and glucagon…
A recent medRxiv preprint comparing semaglutide (e.g., Ozempic, Wegovy) and tirzepatide (e.g., Mounjaro, Zepbound) found that people starting tirzepatide experienced modestly greater…
GLP-1 medications such as Ozempic and Wegovy have transformed treatment for type 2 diabetes and obesity because many patients see substantial blood-sugar improvements and weight loss.
Eli Lilly’s newly approved GLP-1 weight-loss pill, Foundayo, is now available through Amazon-linked channels, including One Medical kiosks and same-day delivery from Amazon Pharmacy.